Publications by authors named "Rohit M Oemrawsingh"

Claim this Profile
S
Sex-based differences in biomarker trajectories in acute coronary syndrome patients from the BIOMArCS study.
Christiane Gärtner, Monique E Ten Haaf, K Martijn Akkerhuis, Rohit M Oemrawsingh, Ron H van Schaik

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of SYNTAX score, intravascular ultrasound and near-infrared spectroscopy in coronary disease: 12-year follow-up of ATHEROREMO.
Victor G Meuleman, Alexander Vanmaele, Jose M Da Veiga Fernandes de Mira, K Martijn Akkerhuis, Rohit M Oemrawsingh

Clin Res Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial.
Frans B Mensink, Jonathan Los, Mohamed M Reda Morsy, Rohit M Oemrawsingh, Clemens von Birgelen

EuroIntervention· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Sirolimus-Versus Paclitaxel-Coated Balloons in Coronary Artery Disease: One-Year Results of Two Real-World Prospective Registries.
Selina Vlieger, Jin M Cheng, Filippo Luca Gurgoglione, Tay M Heang, Alexander J J Ijsselmuiden, Rohit M Oemrawsingh

Catheter Cardiovasc Interv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefinition of Myocardial Infarction After Cardiac Surgery: A two-centre Clinical Evaluation of the Proposed European Association for Cardio-thoracic Surgery Algorithm for the Diagnosis of Perioperative Myocardial Injury and Infarction.
Maaike S Y Thio, Peter G Noordzij, Henk J T Ruven, Ted Reniers, Jurriën M Ten Berg, Rohit M Oemrawsingh

Eur J Cardiothorac Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial.
Valeria Paradies, Nicolas M Van Mieghem, Rohit M Oemrawsingh, Gert Richardt, Giovanni Esposito

EuroIntervention· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-risk plaques in non-culprit lesions and clinical outcome after NSTEMI vs. STEMI.
Rick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, Renicus S Hermanides, Martijn Meuwissen, Rohit M Oemrawsingh

Eur Heart J Cardiovasc Imaging· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
Ulf Landmesser, Ziad A Ali, Akiko Maehara, Mitsuaki Matsumura, Richard A Shlofmitz, Rohit M Oemrawsingh

Eur Heart J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.
Rick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, Renicus S Hermanides, Martijn Meuwissen, Rohit M Oemrawsingh

Atherosclerosis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled Trial.
Pieter C Smits, Pim A L Tonino, Sjoerd H Hofma, Jan-Peter van Kuijk, Fabrizio Spano, Rohit M Oemrawsingh

Circ Cardiovasc Interv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trial.
Frans B Mensink, Jonathan Los, Rohit M Oemrawsingh, Clemens von Birgelen, Alexander Ijsselmuiden

Heliyon· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medically Treated Nonischemic Thin-Cap Fibroatheroma Lesions Versus Fractional Flow Reserve-Guided Complete Revascularization in Diabetic Patients.
Tobias M Hommels, Renicus S Hermanides, Enrico Fabris, Krzysztof P Malinowski, Balázs Berta, Rohit M Oemrawsingh

J Soc Cardiovasc Angiogr Interv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality Risk.
Marie de Bakker, Niels T B Scholte, Rohit M Oemrawsingh, Victor A Umans, Bas Kietselaer

J Am Heart Assoc· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
Daimy M M Dillen, Pieter Jan Vlaar, Amy J E Vermeer, Valeria Paradies, Jan-Peter van Kuijk, Rohit M Oemrawsingh

Am Heart J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction.
Jan-Quinten Mol, Rick H J A Volleberg, Anouar Belkacemi, Renicus S Hermanides, Martijn Meuwissen, Rohit M Oemrawsingh

JAMA Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Supraflex Cruz 60 μm Versus Ultimaster Tansei 80 μm Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trial.
Valeria Paradies, Matteo Maurina, Pim Tonino, Sjoerd H Hofma, Jeroen Vos, Rohit M Oemrawsingh

Am J Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.
Muhammed T Gürgöze, K Martijn Akkerhuis, Rohit M Oemrawsingh, Victor A W M Umans, Bas Kietselaer

Eur Heart J Acute Cardiovasc Care· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of multisite artery disease on clinical outcomes after percutaneous coronary intervention: an analysis from the e-Ultimaster registry.
Ofer Kobo, Majdi Saada, Clemens von Birgelen, Pim A L Tonino, Andres Íñiguez-Romo, Rohit M Oemrawsingh

Eur Heart J Qual Care Clin Outcomes· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of syntax score, intravascular ultrasound and near-infrared spectroscopy to identify low-risk patients with coronary artery disease 5-year results from the ATHEROREMO and IBIS-3 cohorts.
Selina Vlieger, Rohit M Oemrawsingh, Jin M Cheng, Anne-Sophie Schuurman, Maxime Vroegindewey

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification.
Mohamed O Mohamed, Pablo Lamellas, Ariel Roguin, Rohit M Oemrawsingh, Alexander J J Ijsselmuiden

J Am Heart Assoc· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Performance of a Paclitaxel Drug-Coated Balloon in Real-World Percutaneous Coronary Intervention Practice: The PEARL Registry.
Selina Vlieger, Jin M Cheng, Rohit M Oemrawsingh, Auke P J D Weevers, Jawed Polad

J Invasive Cardiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation of Iron Status to Prognosis After Acute Coronary Syndrome.
Muhammed T Gürgöze, Isabella Kardys, K Martijn Akkerhuis, Rohit M Oemrawsingh, Hilde E Groot

Am J Cardiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience.
Kai Ninomiya, Patrick W Serruys, Scot Garg, Hironori Hara, Shinichiro Masuda, Rohit M Oemrawsingh

Rev Cardiovasc Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study.
Jan-Quinten Mol, Anouar Belkacemi, Rick Hja Volleberg, Martijn Meuwissen, Alexey V Protopopov, Rohit M Oemrawsingh

BMJ Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Evolution of Serum Concentrations of High-Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission.
Victor J van den Berg, Rohit M Oemrawsingh, Victor A W M Umans, Isabella Kardys, Folkert W Asselbergs

J Am Heart Assoc· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis